Dyne Therapeutics Inc (NASDAQ: DYN) is 216.39% higher on its value in year-to-date trading and has touched a low of $6.40 and a high of $45.46 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The DYN stock was last observed hovering at around $42.91 in the last trading session, with the day’s loss setting it -0.83%.
Currently trading at $42.08, the stock is 2.51% and 16.55% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.0 million and changing -1.93% at the moment leaves the stock 81.42% off its SMA200. DYN registered 255.41% gain for a year compared to 6-month gain of 96.64%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 21.44% loss in the last 1 month and extending the period to 3 months gives it a 62.91%, and is -1.45% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.74% over the week and 5.34% over the month.
Dyne Therapeutics Inc (DYN) has around 141 employees, a market worth around $4.12B and $0.00M in sales. Distance from 52-week low is 557.50% and -7.42% from its 52-week high. The company has generated returns on investments over the last 12 months (-51.49%).
The EPS is expected to grow by 23.78% this year
The shares outstanding are 97.88M, and float is at 68.32M with Short Float at 13.53%.
Dyne Therapeutics Inc (DYN) Insider Activity
The most recent transaction is an insider sale by HIGH SUSANNA GATTI, the company’s Chief Operating Officer. SEC filings show that HIGH SUSANNA GATTI sold 10,163 shares of the company’s common stock on Jun 24 ’24 at a price of $35.33 per share for a total of $0.36 million. Following the sale, the insider now owns 0.15 million shares.
Dyne Therapeutics Inc disclosed in a document filed with the SEC on Jun 21 ’24 that HIGH SUSANNA GATTI (Chief Operating Officer) sold a total of 29,787 shares of the company’s common stock. The trade occurred on Jun 21 ’24 and was made at $35.01 per share for $1.04 million. Following the transaction, the insider now directly holds 0.15 million shares of the DYN stock.
Still, SEC filings show that on Jun 12 ’24, HIGH SUSANNA GATTI (Chief Operating Officer) disposed off 40,000 shares at an average price of $33.36 for $1.33 million. The insider now directly holds 148,792 shares of Dyne Therapeutics Inc (DYN).
